Cargando…

Therapeutic Potential of a Small-Molecule STAT3 Inhibitor in a Mouse Model of Colitis

SIMPLE SUMMARY: We used the dextran sodium sulfate (DSS) murine model of colitis, which is widely used in preclinical studies, to determine the contribution of STAT3 to IBD. STAT3 has two isoforms: (STAT3α; which has pro-inflammatory and anti-apoptotic functions, and STAT3β; which attenuates the eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Prema, Montoya, Kelsey, Magness, Emily, Rodriguez, Emma, Villalobos, Viviana, Engineer, Nikita, Yang, Peng, Bharadwaj, Uddalak, Eckols, Thomas Kris, Tweardy, David John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251885/ https://www.ncbi.nlm.nih.gov/pubmed/37296943 http://dx.doi.org/10.3390/cancers15112977

Ejemplares similares

Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn’s Disease
por: Robinson, Prema, et al.
Publicado: (2022)

Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance
por: Robinson, Prema, et al.
Publicado: (2016)

Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2016)

Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment
por: Kasembeli, Moses M., et al.
Publicado: (2018)

Correction: Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2019)

Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer
por: Bharadwaj, Uddalak, et al.
Publicado: (2014)

Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
por: Bharadwaj, Uddalak, et al.
Publicado: (2020)

DRUG-REPOSITIONING SCREENING IDENTIFIED PIPERLONGUMINE AS A DIRECT STAT3 INHIBITOR WITH POTENT ACTIVITY AGAINST BREAST CANCER
por: Bharadwaj, Uddalak, et al.
Publicado: (2014)

Modulation of STAT3 Folding and Function by TRiC/CCT Chaperonin
por: Kasembeli, Moses, et al.
Publicado: (2014)

Aberrant function of pathogenic STAT3 mutant proteins is linked to altered stability of monomers and homodimers
por: Kasembeli, Moses M., et al.
Publicado: (2023)

Substance P Causes Seizures in Neurocysticercosis
por: Robinson, Prema, et al.
Publicado: (2012)

Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity
por: Legi, Ashiq, et al.
Publicado: (2021)

Piperlongumine Blocks JAK2-STAT3 to Inhibit Collagen-Induced Platelet Reactivity Independent of Reactive Oxygen Species(†)
por: Yuan, Hengjie, et al.
Publicado: (2015)

Correction: Piperlongumine Blocks JAK2-STAT3 to Inhibit Collagen-Induced Platelet Reactivity Independent of Reactive Oxygen Species(†)
por: Yuan, Hengjie, et al.
Publicado: (2016)

Modulation of the Unfolded Protein Response During Hepatocyte and Cardiomyocyte Apoptosis In Trauma/Hemorrhagic Shock
por: Thacker, Stephen A., et al.
Publicado: (2013)

Chemical Probes that Competitively and Selectively Inhibit Stat3 Activation
por: Xu, Xuejun, et al.
Publicado: (2009)

Substance P Signaling Contributes to Granuloma Formation in Taenia crassiceps Infection, a Murine Model of Cysticercosis
por: Garza, Armandina, et al.
Publicado: (2010)

Substance P Receptor Antagonism: A Potential Novel Treatment Option for Viral-Myocarditis
por: Robinson, Prema, et al.
Publicado: (2015)

TTI-101: A competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic pain
por: Kasembeli, Moses M., et al.
Publicado: (2021)

Somatostatin Negatively Regulates Parasite Burden and Granulomatous Responses in Cysticercosis
por: Khumbatta, Mitra, et al.
Publicado: (2014)

Corrigendum to “Somatostatin Negatively Regulates Parasite Burden and Granulomatous Responses in Cysticercosis”
por: Khumbatta, Mitra, et al.
Publicado: (2015)

Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer
por: Liang, Xujun, et al.
Publicado: (2014)

Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer
por: Zundler, Sebastian, et al.
Publicado: (2016)

Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model
por: Dave, Bhuvanesh, et al.
Publicado: (2012)

A mix of S and ΔS variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture
por: Zheng, M, et al.
Publicado: (2016)

Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression
por: Bharadwaj, Uddalak, et al.
Publicado: (2011)

Correction: Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model
por: Dave, Bhuvanesh, et al.
Publicado: (2012)

Prevention of Hypovolemic Circulatory Collapse by IL-6 Activated Stat3
por: Alten, Jeffrey A., et al.
Publicado: (2008)

Correction: Prevention of Hypovolemic Circulatory Collapse by IL-6 Activated Stat3
por: Alten, Jeffrey A., et al.
Publicado: (2008)

TRIM27 mediates STAT3 activation at retromer-positive structures to promote colitis and colitis-associated carcinogenesis
por: Zhang, Hong-Xia, et al.
Publicado: (2018)

Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer
por: Huang, Jia-Rong, et al.
Publicado: (2020)

Balancing STAT Activity as a Therapeutic Strategy
por: Polak, Kelsey L., et al.
Publicado: (2019)

Small molecules related to adrenomedullin reduce tumor burden in a mouse model of colitis-associated colon cancer
por: Ochoa-Callejero, Laura, et al.
Publicado: (2017)

IL-6-Mediated Activation of Stat3α Prevents Trauma/Hemorrhagic Shock-Induced Liver Inflammation
por: Moran, Ana, et al.
Publicado: (2011)

Substance P—Friend or Foe
por: Robinson, Prema, et al.
Publicado: (2022)

Add-On Therapies in Cardiovascular Disease: Reviewing ICER’s Report and the Potential Effect on Payers
por: Magness, Jonathan W., et al.
Publicado: (2020)

Myeloid STAT3 promotes formation of colitis-associated colorectal cancer in mice
por: Pathria, Paulina, et al.
Publicado: (2015)

Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn’s disease
por: Cordes, Friederike, et al.
Publicado: (2020)

Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis
por: Rodriguez, Emma, et al.
Publicado: (2021)

YAP Activates STAT3 Signalling to Promote Colonic Epithelial Cell Proliferation in DSS-Induced Colitis and Colitis Associated Cancer
por: Deng, Feihong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_45j2tsv2d1h08lg152kv901vuo